title: Reverse osmosis as a means of water for injection production: a response to the position of the European Medicines Agency.
authors.affiliation: Capitola Consultancy, 8103 Hampden Lane, Bethesda, MD 20814, USA. theodorehmeltzer@hotmail.com
authors.forename: T H
authors.initials: TH
authors.lastname: Meltzer
authors.forename: R C
authors.initials: RC
authors.lastname: Livingston
authors.forename: R E
authors.initials: RE
authors.lastname: Madsen
authors.forename: M W
authors.initials: MW
authors.lastname: Jornitz
authors.forename: R M
authors.initials: RM
authors.lastname: Johnson
authors.forename: M W
authors.initials: MW
authors.lastname: Mittelman
mesh_terms: D018441:Biofilms; D003257:Consumer Product Safety; D004304:Dosage Forms; D004340:Drug Contamination / Q000517:prevention & control*; D005060:Europe; D006077:Government Agencies; D017408:Guidelines as Topic; D006801:Humans; D007267:Injections; D008004:Licensure; D009995:Osmosis; D012308:Risk Management; D013242:Sterilization / Q000331:legislation & jurisprudence / Q000592:standards; D013678:Technology, Pharmaceutical / Q000331:legislation & jurisprudence / Q000379:methods* / Q000592:standards; D014867:Water / Q000008:administration & dosage* / Q000032:analysis*; D014871:Water Microbiology; D018508:Water Purification / Q000331:legislation & jurisprudence / Q000592:standards
chemical_list: D004304:Dosage Forms; D014867:Water